Product NDC: | 51879-170 |
Proprietary Name: | StaphAseptic |
Non Proprietary Name: | benzethonium chloride, lidocaine hydrochloride |
Active Ingredient(s): | 2; 25 mg/g; mg/g & nbsp; benzethonium chloride, lidocaine hydrochloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51879-170 |
Labeler Name: | Tec Laboratories, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part348 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20060522 |
Package NDC: | 51879-170-44 |
Package Description: | 144 PACKET in 1 CARTON (51879-170-44) > 1.77 g in 1 PACKET (51879-170-16) |
NDC Code | 51879-170-44 |
Proprietary Name | StaphAseptic |
Package Description | 144 PACKET in 1 CARTON (51879-170-44) > 1.77 g in 1 PACKET (51879-170-16) |
Product NDC | 51879-170 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | benzethonium chloride, lidocaine hydrochloride |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20060522 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Tec Laboratories, Inc. |
Substance Name | BENZETHONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE |
Strength Number | 2; 25 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes |